T1	Participants 36 49	rectal cancer
T2	Participants 145 167	rectal cancer patients
T3	Participants 323 348	rectal carcinoma patients
T4	Participants 467 573	51 rectal carcinoma patients without distant metastasis or peritoneal carcinomatosis were randomly divided
T5	Participants 1436 1461	rectal carcinoma patients
